Soliciting the Oral Route as a Logical Approach to Managing Colon Cancer.
作者信息
Sabra Rayan, Billa Nashiru
机构信息
School of Pharmacy, University of Nottingham, Semenyih, Malaysia.
College of Pharmacy, QU Health, Qatar University, Doha, Qatar.
出版信息
Front Bioeng Biotechnol. 2021 Feb 25;9:645923. doi: 10.3389/fbioe.2021.645923. eCollection 2021.
Abstract
摘要
相似文献
1
Soliciting the Oral Route as a Logical Approach to Managing Colon Cancer.寻求口服途径作为管理结肠癌的合理方法。
Front Bioeng Biotechnol. 2021 Feb 25;9:645923. doi: 10.3389/fbioe.2021.645923. eCollection 2021.
2
The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.纳米颗粒及载纳米颗粒微胶囊经口给药后在小鼠体内的命运：对其结肠特异性递送潜力的评估。
Eur J Pharm Biopharm. 2015 Aug;94:393-403. doi: 10.1016/j.ejpb.2015.06.014. Epub 2015 Jun 25.
3
Optimization of chitosan nanoparticles for colon tumors using experimental design methodology.采用实验设计方法优化壳聚糖纳米粒用于结肠肿瘤。
Artif Cells Nanomed Biotechnol. 2016 Dec;44(8):1917-1926. doi: 10.3109/21691401.2015.1111236. Epub 2015 Dec 17.
4
Newly Designed Silica-Containing Redox Nanoparticles for Oral Delivery of Novel TOP2 Catalytic Inhibitor for Treating Colon Cancer.新型含硅氧化还原纳米颗粒用于口服递送新型拓扑异构酶 2 催化抑制剂治疗结肠癌。
Adv Healthc Mater. 2017 Oct;6(20). doi: 10.1002/adhm.201700428. Epub 2017 Jul 24.
5
Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action.抗癌人参皂苷25 - OCH3 - PPD的口服纳米递送，MDM2癌基因的天然抑制剂：纳米颗粒制备、表征、体外和体内抗前列腺癌活性及作用机制
Oncotarget. 2015 Aug 28;6(25):21379-94. doi: 10.18632/oncotarget.4091.
6
Colon targeting: an emerging frontier for oral insulin delivery.结肠靶向：口服胰岛素传递的新兴前沿。
Expert Opin Drug Deliv. 2013 Jun;10(6):731-9. doi: 10.1517/17425247.2013.782284. Epub 2013 Mar 25.
7
Improving Efficacy, Oral Bioavailability, and Delivery of Paclitaxel Using Protein-Grafted Solid Lipid Nanoparticles.使用蛋白质接枝固体脂质纳米粒提高紫杉醇的疗效、口服生物利用度及递送效果
Mol Pharm. 2016 Nov 7;13(11):3903-3912. doi: 10.1021/acs.molpharmaceut.6b00691. Epub 2016 Oct 13.
8
A nanomedicine-promising approach to provide an appropriate colon-targeted drug delivery system for 5-fluorouracil.一种有望为5-氟尿嘧啶提供合适的结肠靶向给药系统的纳米医学方法。
Int J Nanomedicine. 2015 Nov 23;10:7175-82. doi: 10.2147/IJN.S89030. eCollection 2015.
9
Chylomicron mimicking solid lipid nanoemulsions encapsulated enteric minicapsules targeted to colon for immunization against hepatitis B.模拟乳糜微粒的固体脂质纳米乳液包封肠靶向微胶囊用于乙型肝炎免疫接种。
Int Immunopharmacol. 2019 Jan;66:317-329. doi: 10.1016/j.intimp.2018.11.041. Epub 2018 Nov 29.
10
Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.靶向口腔药物传递系统至结肠的策略及其在结直肠癌治疗中的潜在应用。
Pharm Dev Technol. 2012 Sep-Oct;17(5):521-40. doi: 10.3109/10837450.2012.696268. Epub 2012 Jun 8.
引用本文的文献
1
A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles.脂质纳米粒增强经口递药的窗口。
Drug Des Devel Ther. 2024 Feb 29;18:613-630. doi: 10.2147/DDDT.S439975. eCollection 2024.
本文引用的文献
1
A new prodrug and bioactivity evaluation of methotrexate based on Chitosan.基于壳聚糖的甲氨蝶呤新型前药及其生物活性评价
Heliyon. 2020 Jun 18;6(6):e04223. doi: 10.1016/j.heliyon.2020.e04223. eCollection 2020 Jun.
2
Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer.壳聚糖-果胶（修饰）复合纳米载药系统用于靶向结肠癌的治疗
Int J Pharm. 2019 Dec 15;572:118775. doi: 10.1016/j.ijpharm.2019.118775. Epub 2019 Oct 31.
3
Curcumin Nanoformulations for Colorectal Cancer: A Review.用于结直肠癌的姜黄素纳米制剂：综述
Front Pharmacol. 2019 Mar 5;10:152. doi: 10.3389/fphar.2019.00152. eCollection 2019.
4
Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.载姜黄素壳聚糖-海藻酸钠复合纳米粒的药代动力学和抗结肠癌特性。
J Biomater Sci Polym Ed. 2018 Dec;29(18):2281-2298. doi: 10.1080/09205063.2018.1541500. Epub 2018 Dec 28.
5
Drug resistance and new therapies in colorectal cancer.结直肠癌的耐药性和新疗法。
World J Gastroenterol. 2018 Sep 14;24(34):3834-3848. doi: 10.3748/wjg.v24.i34.3834.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
Formulation and evaluation of pH-sensitive rutin nanospheres against colon carcinoma using HCT-116 cell line.使用HCT - 116细胞系制备pH敏感型芦丁纳米球并评估其对结肠癌的作用
J Adv Res. 2017 Oct 12;9:17-26. doi: 10.1016/j.jare.2017.10.003. eCollection 2018 Jan.
8
Controversial issues in radiotherapy for rectal cancer: a systematic review.直肠癌放射治疗中的争议问题：一项系统综述
Radiat Oncol J. 2017 Dec;35(4):295-305. doi: 10.3857/roj.2017.00395. Epub 2017 Dec 29.
9
Drug delivery of oral anti-cancer fluoropyrimidine agents.口服抗癌氟嘧啶类药物的递药系统
Expert Opin Drug Deliv. 2017 Dec;14(12):1355-1366. doi: 10.1080/17425247.2017.1316260. Epub 2017 Apr 11.
10
Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature.患者报告的癌症治疗中口服与静脉给药的偏好：文献综述
Patient Prefer Adherence. 2016 Aug 24;10:1609-21. doi: 10.2147/PPA.S106629. eCollection 2016.
Zotero 插件